Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Istanbul - Delayed Quote TRY

Turk Ilac Ve Serum Sanayi Anonim Sirketi (TRILC.IS)

19.77
+0.28
+(1.44%)
As of 2:55:02 PM GMT+3. Market Open.
Loading Chart for TRILC.IS
  • Previous Close 19.49
  • Open 19.47
  • Bid 19.78 x --
  • Ask 19.78 x --
  • Day's Range 19.43 - 20.54
  • 52 Week Range 15.96 - 39.18
  • Volume 4,684,082
  • Avg. Volume 8,910,863
  • Market Cap (intraday) 3.199B
  • Beta (5Y Monthly) -0.18
  • PE Ratio (TTM) 43.93
  • EPS (TTM) 0.45
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells pharmaceutical products in Turkey. It offers IV Parenteral Solution (Serum), ampoule/vial products, and dialysis solutions. The company was founded in 2010 and is based in Ankara, Turkey.

www.turkilac.com.tr

541

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TRILC.IS

View More

Performance Overview: TRILC.IS

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .

YTD Return

TRILC.IS
18.03%
BIST 100 (XU100.IS)
7.03%

1-Year Return

TRILC.IS
20.28%
BIST 100 (XU100.IS)
9.02%

3-Year Return

TRILC.IS
111.22%
BIST 100 (XU100.IS)
276.01%

5-Year Return

TRILC.IS
277.43%
BIST 100 (XU100.IS)
90.96%

Compare To: TRILC.IS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TRILC.IS

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    3.15B

  • Enterprise Value

    4.80B

  • Trailing P/E

    43.31

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.23

  • Price/Book (mrq)

    1.64

  • Enterprise Value/Revenue

    1.87

  • Enterprise Value/EBITDA

    6.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.82%

  • Return on Assets (ttm)

    9.77%

  • Return on Equity (ttm)

    3.91%

  • Revenue (ttm)

    2.57B

  • Net Income Avi to Common (ttm)

    72.36M

  • Diluted EPS (ttm)

    0.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.41M

  • Total Debt/Equity (mrq)

    85.27%

  • Levered Free Cash Flow (ttm)

    -1.14B

Research Analysis: TRILC.IS

View More

Company Insights: TRILC.IS

Research Reports: TRILC.IS

View More

People Also Watch